Theravance Biopharma, Inc. - COM (TBPH)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
47.1M
Holdings value Q2 2024
$400M
Value change Q2 2024
-$7.98M
Grand Portfolio weight change Q2 2024
0%
Number of holders
129
Number of buys Q2 2024
11
Number of sells Q2 2024
-8
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 939K $7.57M -$96.3K $8.06 23
2024 Q2 47.1M $400M -$7.98M $8.48 129
2024 Q1 47.9M $430M -$10M $8.97 118
2023 Q4 48.8M $549M -$21.3M $11.24 117
2023 Q3 50.8M $439M -$20.8M $8.63 113
2023 Q2 52.8M $546M -$76.4M $10.35 118
2023 Q1 60.2M $653M -$20.6M $10.85 113
2022 Q4 62.1M $696M -$41.9M $11.22 119
2022 Q3 64M $649M +$1.84M $10.14 115
2022 Q2 64.2M $582M +$11.7M $9.06 106
2022 Q1 63M $602M +$31.6M $9.56 116
2021 Q4 59.3M $655M -$7.85M $11.05 110
2021 Q3 60.7M $449M -$37.1M $7.40 117
2021 Q2 60.8M $883M +$107M $14.52 103
2021 Q1 53.5M $1.09B +$7.3M $20.41 109
2020 Q4 53.2M $946M +$17.7M $17.77 103
2020 Q3 52.5M $776M -$4.5M $14.78 113
2020 Q2 53M $1.11B -$95M $20.99 121
2020 Q1 56.9M $1.32B +$268M $23.11 104
2019 Q4 44.8M $1.16B -$103M $25.89 105
2019 Q3 46.2M $900M -$42.3M $19.48 88
2019 Q2 48.6M $794M +$6.06M $16.33 94
2019 Q1 48.5M $1.1B +$14.7M $22.67 99
2018 Q4 47.7M $1.22B -$168K $25.59 92
2018 Q3 47.4M $1.55B +$9.26M $32.67 91
2018 Q2 47.8M $1.08B +$2.24M $22.68 84
2018 Q1 47.7M $1.16B +$19.4M $24.25 87
2017 Q4 46.9M $1.31B -$13.5M $27.89 80
2017 Q3 47.3M $1.62B +$32.4M $34.24 85
2017 Q2 46.3M $1.84B +$49.9M $39.84 92
2017 Q1 45.1M $1.66B +$168M $36.82 93
2016 Q4 43.8M $1.4B +$264M $31.88 96
2016 Q3 35.3M $1.28B +$76.6M $36.24 99
2016 Q2 33.9M $770M +$132M $22.69 95
2016 Q1 28.2M $529M +$42.7M $18.80 77
2015 Q4 25.9M $425M +$85.9M $16.39 78
2015 Q3 20.5M $226M -$24.6M $10.99 78
2015 Q2 22.4M $292M +$16.4M $13.02 84
2015 Q1 20.9M $362M +$7.41M $17.35 82
2014 Q4 20.4M $305M -$32.5M $14.92 86
2014 Q3 21.3M $490M +$13.6M $23.05 85
2014 Q2 20.2M $644M +$644M $31.88 88
2014 Q1 842 $14.6K $0 $17.35 1